Anmelden Kostenlos registrieren

Hancock Jaffe Laboratories Inc Institutionelles Eigentum

Was ist das Institutionelles Eigentum von Hancock Jaffe Laboratories Inc?

Institutionelles Eigentum von Hancock Jaffe Laboratories Inc ist 21.37%

Was ist die Definition von Institutionelles Eigentum?



Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Institutionelles Eigentum von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Hancock Jaffe Laboratories Inc

Was macht Hancock Jaffe Laboratories Inc?

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

Unternehmen mit institutionelles eigentum ähnlich Hancock Jaffe Laboratories Inc